• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Iguana Healthcare Partners raises $54M investment fund | Wall Street Beat

Iguana Healthcare Partners raises $54M investment fund | Wall Street Beat

July 3, 2013 By Arezu Sarvestani

MassDevice.com Wall Street Beat

New York-based lifesciences investment group Iguana Healthcare Partners filed an amended notice, reporting that the company has raised more than $53.5 million in pooled investment fund interests.

The funding, raised among 20 unnamed investors, will support Iguana’s interests in pharmaceuticals, biotechnology, medical devices, diagnostics, healthcare services and healthcare information technology.

"Our research strategy is bottom-up and stock-by-stock and will focus on innovation and pharmaco-economics as a driver of sales and earnings growth," according to the company’s website. "Global and sector-specific risk will be actively managed with an eye on capital preservation."

The fundraising efforts began Jan. 4, 2010, and is set to expire Aug. 31, 2015, according to an SEC filing.

Rumor: Orscan Tech. plans IPO on Tel Aviv Stock Exchange
An Israeli newspaper cites inside sources with rumors that medical imaging company Orscan Technologies will launch an initial public offering on the Tel Aviv Stock Exchange, the value of which is not yet clear.
Read more

Endologix raises 2013 guidance in strong Q2 growth
Irvine, Calif.-based Endologix raised its 2013 revenue guidance, now expecting $128-$134 million after posting 33% growth in its 2nd quarter. Read more

Medtronic and Urologix rework payment plan
Urologix’s (NSDQ:ULGX) announced that it restructured its payment obligation to medtech titan Medtronic (NYSE:MDT) for the licensing of the Prostiva radiofrequency therapy system. Read more

Philips Healthcare and Radiological sign licensing & distribution contract
Missouri-based Radiologica signed a long-term licensing and distribution contract with healthcare giant Philips Healthcare (NYSE:PHG), who will sell Radiologica’s fullAccess radiation oncology systems. Read more

Analysts’ ups and downs

  • Align Technology (NSDQ:ALGN): Robert W. Baird initiates coverage with “outperform” rating, $45 price target
  • Haemonetics (NYSE:HAE): Zacks reiterates “outperform” rating, $50.00 price target
  • Hanger (NYSE:HGR): Sidoti initiates coverage with “buy” rating
  • Mallinckrodt plc (NYSE: MNK): R. F. Lafferty initiates coverage with “sell” rating
  • Thoratec (NSDQ:THOR): Leerink Swann reiterates "outperform" rating, lowers price target to $38 from $43

Filed Under: Funding Roundup, News Well, Wall Street Beat Tagged With: Endologix, Iguana Healthcare Partners, Orscan Technologies, Philips, Radiologica, Urologix Inc.

More recent news

  • Vicarious Surgical inks surgical robot collab with hospital, eyes first clinical patients
  • Bioliberty launches hub for soft-robotic wearable devices
  • Zynex submits laser pulse oximeter to FDA
  • Roche invests $550M to make Indianapolis a CGM manufacturing hub
  • Product liability lawsuits target Medtronic, Boston Scientific spinal cord stim tech

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy